In patients who are event-free after 3-6 months of DAPT and who are not at high ischaemic risk, what change in antithrombotic therapy…

…at target doses. The patient and his family are asking about the potential benefits of an implantable cardioverter-defibrillator (ICD) for primary prevention. What is…

…of 55 mL/min/1.73 m². You are discussing the initiation of tafamidis therapy to improve cardiovascular outcomes. Which of the following is the…

…He appears disoriented and his vitals are unstable. An ECG is performed urgently. The patient's ECG is presented below. Which alternatives below are correct…

…SVT. Compared to SVT patients who have underlying cardiovascular disease, which of the following clinical characteristics is most likely to be observed in this patient…

…valve replacement. He is a professional athlete who wishes to avoid lifelong oral anticoagulation and is inquiring about alternatives to a mechanical heart valve. Which…

…trial is designed to evaluate the efficacy of a novel anti-thrombotic agent in patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS…

…the following intravenous medications has been evaluated for termination of sustained monomorphic VT in patients with coronary artery disease with or without healed myocardial infarction…

A patient's ECG shows intermittently non-conducted P waves with a fixed PR interval. What type of AV block does this describe, and what…

This 54-year-old patient with Covid-19 (Sars-Cov-2) has a slightly irregular rhythm. What is the rhythm and should you be concerned…

A 64 year old male patient with hypertension. ECG is recorded during his annual health screening. He is asymptomatic during the recording. Heart rate 67…

…primary care physician due to palpitations. The palpitations occurs intermittently, but they tend to intensify during stressful periods, such as exam periods. The patient experiences…